MedPath
FDA Product

ciprofloxacin

Product approved by U.S. Food and Drug Administration (US)

Basic Information

ciprofloxacin

53002-2790

Regulatory Information

53002-2790

ANDA076639

C73584

May 5, 2022

USA

These highlights do not include all the information needed to use CIPROFLOXACIN TABLETS safely and effectively. See full prescribing information for CIPROFLOXACIN TABLETS. CIPROFLOXACIN tablet, for oral use Initial U.S. Approval: 1987

Human Prescription Drug Label

10

Company Information

147096275

Active Ingredients

CIPROFLOXACIN HYDROCHLORIDE

Quantity: 250 mg in 1 1

Code: 4BA73M5E37

Class Code: ACTIM

STARCH, CORN

Code: O8232NY3SJ

Class Code: IACT

HYPROMELLOSE, UNSPECIFIED

Code: 3NXW29V3WO

Class Code: IACT

MICROCRYSTALLINE CELLULOSE

Code: OP1R32D61U

Class Code: IACT

SILICON DIOXIDE

Code: ETJ7Z6XBU4

Class Code: IACT

MAGNESIUM STEARATE

Code: 70097M6I30

Class Code: IACT

TITANIUM DIOXIDE

Code: 15FIX9V2JP

Class Code: IACT

CROSPOVIDONE (15 MPA.S AT 5%)

Code: 68401960MK

Class Code: IACT

POLYETHYLENE GLYCOL, UNSPECIFIED

Code: 3WJQ0SDW1A

Class Code: IACT

WATER

Code: 059QF0KO0R

Class Code: IACT

Active Moieties

CIPROFLOXACIN

Code: 5E8K9I0O4U

© Copyright 2025. All Rights Reserved by MedPath